Drug Profile
Research programme: allergy prophylaxis - Protectimmun
Alternative Names: Antiallergy vaccine - ProtectimmunLatest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator Protectimmun
- Class Allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Allergic asthma; Hypersensitivity; Seasonal allergic rhinitis
Most Recent Events
- 14 Sep 2023 Discontinued - Preclinical for Allergic asthma (Prevention) in Germany (Intranasal) (Protectimmun pipeline, September 2023)
- 14 Sep 2023 Discontinued - Preclinical for Hypersensitivity (Prevention) in Germany (Intranasal) (Protectimmun pipeline, September 2023)
- 14 Sep 2023 Discontinued - Preclinical for Seasonal allergic rhinitis (Prevention) in Germany (Intranasal) (Protectimmun pipeline, September 2023)